Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium

Trial Profile

Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Delirium
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 11 May 2010 Planned number of patients (130) added as reported by ClinicalTrials.gov record.
    • 11 May 2010 Planned end date (1 Sep 2011) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top